Cargando…
miR-143-3p Targets lncRNA PSMG3-AS1 to Inhibit the Proliferation of Hepatocellular Carcinoma Cells
INTRODUCTION: The molecular pathogenesis of liver cancer remains unclear; some ncRNAs have been considered as potential drug targets for cancer treatment. LncRNA PSMG3‑AS1 has been reported to promote breast cancer, while its role in hepatocellular carcinoma (HCC) is unknown. METHODS: Bioinformatics...
Autores principales: | Zhang, Jianlin, Huang, Jin, Chen, Weidong, Hu, Zhiwan, Wang, Xingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394512/ https://www.ncbi.nlm.nih.gov/pubmed/32801875 http://dx.doi.org/10.2147/CMAR.S242179 |
Ejemplares similares
-
Novel lncRNA PSMG3-AS1 functions as a miR-143-3p sponge to increase the proliferation and migration of breast cancer cells
por: Cui, Yue, et al.
Publicado: (2020) -
MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma
por: Yue, Na, et al.
Publicado: (2020) -
miR-4417 targets lncRNA PSMG3-AS1 to suppress cell invasion and migration in cervical squamous cell carcinoma
por: Man, Shuhong, et al.
Publicado: (2021) -
LncRNA TRG-AS1 stimulates hepatocellular carcinoma progression by sponging miR-4500 to modulate BACH1
por: Sun, Xuehu, et al.
Publicado: (2020) -
Inhibition of lncRNA TMPO-AS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR-143-3p
por: Zhao, Lei, et al.
Publicado: (2020)